A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
Henan Cancer Hospital
Genmab
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
University of Chicago
Fred Hutchinson Cancer Center
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Gilead Sciences
The Lymphoma Academic Research Organisation
Sana Biotechnology
University of Arizona
Case Comprehensive Cancer Center
Celgene
City of Hope Medical Center
Sana Biotechnology
University of Maryland, Baltimore
National Taiwan University Hospital
Universität des Saarlandes
Acepodia Biotech, Inc.
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Adicet Therapeutics
The First Affiliated Hospital of Nanchang University
Peking University Cancer Hospital & Institute
City of Hope Medical Center
Janssen Research & Development, LLC
Fred Hutchinson Cancer Center
MEI Pharma, Inc.
University of Nebraska
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
Fate Therapeutics
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Universität des Saarlandes
Universität des Saarlandes
Roswell Park Cancer Institute
German High-Grade Non-Hodgkin's Lymphoma Study Group
Masonic Cancer Center, University of Minnesota